ArticleMolecular therapy. Methods & clinical development2016

Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells.

David L DiGiusto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.